NovaBay Pharmaceuticals, Inc. (NBY) Reports First Quarter 2014 Financial Results And A Clinical/Business Update
5/1/2014 3:25:59 PM
NovaBay Pharmaceuticals, Inc. (NYSE MKT:NBY), clinical-stage biopharmaceutical company developing non-antibiotic, topical antimicrobial products, today reported first quarter 2014 financial results and provided an update on clinical progress.
Help employers find you! Check out all the jobs and post your resume.
comments powered by